Skip to main content

Advising Pharmakon in its $646 million secured financing

Sep 5, 2024

Our work
A man in a business suit signing a legal contract.

We are proud to support Akin in advising Pharmakon in its $646 million secured financing to fund Collegium’s acquisition of Ironshore Therapeutics.

Pharmakon Advisors, LP and its affiliated funds provided Collegium Pharmaceutical with a $646 million secured financing to be used to help fund Collegium’s acquisition of Ironshore Therapeutics Inc., a privately held, pharmaceutical company.

Our Finance team acted as Cayman Islands counsel to Pharmakon Advisors, LP. The team was led by partner Justin Hart with assistance from associate Samuel Buchan, based in Cayman Islands.

Media contacts

Jamie Harley

Global Head of Communications

/+44 (0) 7903 051 790

Key contacts

Get in touch with our team

Get the latest insights and expertise in your inbox 

Fluid ink image
Sign up